Commit Biologics is a biotechnology research company developing a novel immunotherapy platform for the treatment of cancer.
Commit Biologics has raised $5.7M in total funding. The most recent round was Seed. The last funding was announced in January 2025.
Commit Biologics's investors include Novo Holdings, Korys, Bioqube Ventures, Innovation Fund Denmark, BioInnovation Institute.
Commit Biologics is headquartered in Aarhus, Denmark.
Commit Biologics is a biotechnology research company developing a novel immunotherapy platform for the treatment of cancer.
Commit Biologics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Commit Biologics — Funding & Investors." VCBacked, January 28, 2025, https://www.vcbacked.co/company/commit-biologics. Accessed August 1, 2026.
VCBacked. (2025). Commit Biologics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/commit-biologics
{{cite web |title=Commit Biologics — Funding & Investors |url=https://www.vcbacked.co/company/commit-biologics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated